Yahoo
HKSE - Delayed Quote HKD

Besunyen Holdings Company Limited (0926.HK)

2.350 0.000 (0.00%)
At close: October 15 at 10:05:49 AM GMT+8
Chart Range Bar
Loading chart for 0926.HK
  • Previous Close 2.350
  • Open 2.350
  • Bid 2.350 x --
  • Ask --
  • Day's Range 2.350 - 2.350
  • 52 Week Range 2.320 - 2.860
  • Volume 25
  • Avg. Volume 916
  • Market Cap (intraday) 287.324M
  • Beta (5Y Monthly) 1.20
  • PE Ratio (TTM) 11.19
  • EPS (TTM) 0.210
  • Earnings Date --
  • Forward Dividend & Yield 0.15 (0.00%)
  • Ex-Dividend Date Aug 27, 2025
  • 1y Target Est --

Besunyen Holdings Company Limited manufactures and sells therapeutic tea products and pharmaceuticals in the People's Republic of China. It operates through Tea Products; and Weight-Loss and Other Medicines segments. The company offers therapeutic tea products, such as detox, slimming, fit, and relief tea under the Besunyen brand, as well as other tea products. It also provides Besunyen Orlistat weight-loss medicines, nutrition meal replacements, probiotics, and enzymes. The company sells its products through over-the-counter pharmacies, pharmaceutical third-party terminals, and shops on e-commerce platforms. The company was formerly known as Tea-Care Group Ltd. and changed its name to Besunyen Holdings Company Limited in June 2010. The company was founded in 2000 and is based in Beijing, the People's Republic of China. Besunyen Holdings Company Limited operates as a subsidiary of Foreshore Holding Group Limited.

www.besunyen.com

134

Full Time Employees

December 31

Fiscal Year Ends

Packaged Foods

Industry

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .

YTD Return

0926.HK
1.67%
HANG SENG INDEX (^HSI)
9.11%

1-Year Return

0926.HK
8.91%
HANG SENG INDEX (^HSI)
11.37%

3-Year Return

0926.HK
3.62%
HANG SENG INDEX (^HSI)
33.83%

5-Year Return

0926.HK
43.61%
HANG SENG INDEX (^HSI)
8.21%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    4.28%

  • Return on Assets (ttm)

    3.97%

  • Return on Equity (ttm)

    4.76%

  • Revenue (ttm)

    540.25M

  • Net Income Avi to Common (ttm)

    23.11M

  • Diluted EPS (ttm)

    0.210

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    218.86M

  • Total Debt/Equity (mrq)

    1.18%

  • Levered Free Cash Flow (ttm)

    62.91M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: